Send to:

Choose Destination
See comment in PubMed Commons below
Ann Allergy Asthma Immunol. 2014 Jun;112(6):519-24. doi: 10.1016/j.anai.2014.03.017. Epub 2014 Apr 16.

Effect of vitamin D-binding protein genotype on the development of asthma in children.

Author information

  • 1Section of Respiratory Medicine, Department of Pediatrics, Yale School of Medicine, New Haven, Connecticut.
  • 2Yale Center for Analytical Sciences, Yale School of Public Health, New Haven, Connecticut.
  • 3Departments of Laboratory Medicine and Pathobiology, Medicine, and Genetics, University of Toronto, Toronto, Ontario, Canada.
  • 4Section of Endocrinology, Department of Pediatrics, Yale School of Medicine, New Haven, Connecticut.
  • 5Section of Respiratory Medicine, Department of Pediatrics, Yale School of Medicine, New Haven, Connecticut. Electronic address:



Potential vitamin D-related influences on inflammatory diseases such as asthma are controversial, including the suggestion that vitamin D insufficiency is associated with increased asthma morbidity. Vitamin D-binding protein transports vitamin D metabolites in the circulation. Single nucleotide polymorphisms in the GC gene encoding vitamin D-binding protein are associated with circulating vitamin D metabolite levels in healthy infants and toddlers.


To test the hypothesis that GC single nucleotide polymorphisms encoding the D432E and T436K variants predict subsequent development of asthma in healthy children.


A retrospective medical record review was performed to determine the development of asthma in 776 children in whom GC genotype, vitamin D-binding protein concentration, and circulating 25-hydroxyvitamin D had been determined at 6 to 36 months of age. Demographic and detailed current clinical data were collected and criteria for asthma were recorded.


GC genotype was available for 463 subjects. After an initial analysis of all subject data, the analysis was limited to the predominant Hispanic population (72.1%) to minimize potential confounding effects of ethnicity. Asthma was diagnosed in 87 children (26%). Subjects with the GC genotype encoding the ET/ET (Gc1s/Gc1s) variant had lower odds of developing asthma, representing a protective effect compared with subjects with the DT/DT (Gc1f/Gc1f) variant.


In the Hispanic population of inner-city New Haven, Connecticut, the ET/ET (Gc1s/Gc1s) genotype of vitamin D-binding protein might confer protection against the development of asthma compared with the wild-type genotype DT/DT (Gc1f/Gc1f).

Copyright © 2014 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

[PubMed - indexed for MEDLINE]
[Available on 2015-06-01]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk